Submitted abstracts
Early stage NSCLC
82TiP - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy

https://doi.org/10.1093/annonc/mdz064.014Get rights and content
Under an Elsevier user license
open archive

Cited by (0)